FFCP PHASE2:Hg19::chr14:54863739..54863769,+
From FANTOM5_SSTAR
Jump to: navigation, search
Short description: | p2@CDKN3 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_2_at_CDKN3_5end |
Coexpression cluster: | C3434_prostate_Reticulocytes_mucinous_epidermoid_testis_teratocarcinoma_chronic |
Association with transcript: | 0bp_to_ENST00000434252, ENST00000439312, ENST00000541304_5end |
EntrezGene: | CDKN3 |
HGNC: | 1791 |
UniProt: | F8WEM0F8WDR6F5H232 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p2@CDKN3 |
---|
0
10
20
30
40
50
60
70
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
cancer | 1.34e-47 | 235 |
disease of cellular proliferation | 2.44e-46 | 239 |
cell type cancer | 9.14e-25 | 143 |
organ system cancer | 2.05e-24 | 137 |
carcinoma | 2.16e-22 | 106 |
hematologic cancer | 5.12e-14 | 51 |
immune system cancer | 5.12e-14 | 51 |
leukemia | 6.94e-10 | 39 |
disease of anatomical entity | 4.59e-07 | 39 |
adenocarcinoma | 7.65e-07 | 25 |
Showing 1 to 10 of 10 entries